Literature DB >> 12042666

Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3.

Yue-Hua Huang1, Alema Galijatovic, Nghia Nguyen, Donald Geske, Deirdre Beaton, Judith Green, Mark Green, Wilbert H Peters, Robert H Tukey.   

Abstract

UDP-glucuronosyltransferase (UGT) 1A8 is part of the UGT1 locus and is expressed exclusively in extrahepatic tissues. Analysis of UGT1A8 exon 1 sequence has identified four genotypes from a population of 69 individuals. While there are four alleles, one of the single base pair changes leads to a silent mutation at T255, while the other mutations lead to amino acid substitutions at positions 173 and 277, creating three allelic variants. UGT1A8*1 (A173C277), UGT1A8*1a (T255A>G), UGT1A8*2 (G173C277) and UGT1A8*3 (A173Y277). The allelic frequencies of UGT1A8*1, UGT1A8*1a, UGT1A8*2 and UGT1A8*3 are 0.551, 0.282, 0.145 and 0.022, respectively. To examine the properties of the UGT1A8 proteins, UGT1A8*1 and UGT1A8*2 were cloned from a human colon cDNA library and UGT1A8*3 generated by mutagenesis using UGT1A8*1 as template. The cDNAs were expressed in HK293 cells to examine catalytic function as well as abundance as observed by analysis of UGT1A8-GFP (green fluorescent protein) expression. The single amino acid change that identifies UGT1A8*1 (A173) and UGT1A8*2 (G173) has little impact on function, while the UGT1A8*3 (Y277) is a conserved amino acid alteration represented by a dramatic reduction in catalytic activity. Protein abundance, as determined by Western blot analysis following transient transfection, is not altered. In addition, functional UGT1A8-GFP variants displayed staining in the cytoplasmic region, indicating that each protein is expressed in similar cellular compartments. Together, these data suggest that the null UGT1A8*3 results from structural changes and not a lack of protein expression. Allelic variation leading to singular codon changes could potentially alter drug metabolism in extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042666     DOI: 10.1097/00008571-200206000-00004

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  19 in total

Review 1.  Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.

Authors:  Jacqueline Ramírez; Mark J Ratain; Federico Innocenti
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

Review 2.  The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.

Authors:  Nicolas Picard; Pierre Marquet
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-03-25       Impact factor: 4.481

3.  Cellular asymmetric catalysis by UDP-glucuronosyltransferase 1A8 shows functional localization to the basolateral plasma membrane.

Authors:  Kerstin Ziegler; Sarka Tumova; Asimina Kerimi; Gary Williamson
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

4.  Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

Authors:  Hideaki Kagaya; Kazuyuki Inoue; Masatomo Miura; Shigeru Satoh; Mitsuru Saito; Hitoshi Tada; Tomonori Habuchi; Toshio Suzuki
Journal:  Eur J Clin Pharmacol       Date:  2007-01-09       Impact factor: 2.953

5.  Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese.

Authors:  May-Jen Huang; Sien-Sing Yang; Min-Shung Lin; Ching-Shan Huang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

6.  Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.

Authors:  L'aurelle A Johnson; William S Oetting; Saonli Basu; Susie Prausa; Arthur Matas; Pamala A Jacobson
Journal:  Eur J Clin Pharmacol       Date:  2008-06-21       Impact factor: 2.953

7.  Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes.

Authors:  Yuan Ming Di; Eli Chan; Ming Qian Wei; Jun-Ping Liu; Shu-Feng Zhou
Journal:  AAPS J       Date:  2009-07-02       Impact factor: 4.009

8.  Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo.

Authors:  Dongxiao Sun; Nathan R Jones; Andrea Manni; Philip Lazarus
Journal:  Cancer Prev Res (Phila)       Date:  2013-05-16

9.  Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.

Authors:  Philip Lazarus; Dongxiao Sun
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

10.  Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.

Authors:  Renee M Balliet; Gang Chen; Carla J Gallagher; Ryan W Dellinger; Dongxiao Sun; Philip Lazarus
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.